Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|November 8, 2023
Protection from infection and reinfection due to the Omicron BA.1 variant in care homesSaher Choudhry, Thomas A J Rowland, Kamil McClelland, et al.
Vaccines|November 27, 2021
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert ConsensusRaul Ortiz de Lejarazu-Leonardo, Emanuele Montomoli, Radek Wojcik, et al.
Genome Medicine|July 30, 2020
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoproteinAndrew D Davidson, Maia Kavanagh Williamson, Sebastian Lewis, et al.
Nature Communications|June 9, 2023
Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK childrenAnika Singanayagam, Dimitra Klapsa, Shirelle Burton-Fanning, et al.
The Journal of Infectious Diseases|November 21, 2013
Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronavirusesSudhakar Agnihothram, Robin Gopal, Boyd L Yount, et al.
Influenza and Other Respiratory Viruses|August 25, 2019
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance-opportunities and challengesShobha Broor, Harry Campbell, Siddhivinayak Hirve, et al.
Health Technology Assessment (Winchester, England)|May 31, 2014
Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-oldsKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Wellcome Open Research|January 1, 2026
Enabling genomic surveillance from 30 years of linked English sentinel network data: The Wellcome Quinquagenarian (QQG) Biomedical ResourceSimon de Lusignan, Praveen SebastianPillai, Omid Parvizi, et al.
The Lancet. Infectious Diseases|December 21, 2010
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trialKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Vaccine|April 17, 2009
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccineRebecca J Cox, Abdullah S Madhun, Solveig Hauge, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|November 8, 2023
Protection from infection and reinfection due to the Omicron BA.1 variant in care homesSaher Choudhry, Thomas A J Rowland, Kamil McClelland, et al.
Vaccines|November 27, 2021
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert ConsensusRaul Ortiz de Lejarazu-Leonardo, Emanuele Montomoli, Radek Wojcik, et al.
Genome Medicine|July 30, 2020
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoproteinAndrew D Davidson, Maia Kavanagh Williamson, Sebastian Lewis, et al.
Nature Communications|June 9, 2023
Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK childrenAnika Singanayagam, Dimitra Klapsa, Shirelle Burton-Fanning, et al.
The Journal of Infectious Diseases|November 21, 2013
Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronavirusesSudhakar Agnihothram, Robin Gopal, Boyd L Yount, et al.
Influenza and Other Respiratory Viruses|August 25, 2019
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance-opportunities and challengesShobha Broor, Harry Campbell, Siddhivinayak Hirve, et al.
Health Technology Assessment (Winchester, England)|May 31, 2014
Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-oldsKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Wellcome Open Research|January 1, 2026
Enabling genomic surveillance from 30 years of linked English sentinel network data: The Wellcome Quinquagenarian (QQG) Biomedical ResourceSimon de Lusignan, Praveen SebastianPillai, Omid Parvizi, et al.
The Lancet. Infectious Diseases|December 21, 2010
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trialKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Vaccine|April 17, 2009
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccineRebecca J Cox, Abdullah S Madhun, Solveig Hauge, et al.
Pageof 27